Nasopharyngeal Carcinoma
📧 Sign up to get email alerts when something new happens for Nasopharyngeal Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-01-22Clinical Trial Update: "Xijiang Project" Screening Cohort for NPC
Update on the Xijiang Project screening cohort for nasopharyngeal carcinoma; the study is active but not recruiting.
-
CLINICAL_TRIALS research · 2025-01-17Clinical Trial Update: A Phase II Study of TPF With PD-1 Inhibitor Induction Therapy for Locally Advanced Nasopharyngeal Carcinoma [Phase 2]
Phase II study evaluating TPF chemotherapy with a PD-1 inhibitor as induction therapy for locally advanced nasopharyngeal carcinoma; not yet…
-
CLINICAL_TRIALS research · 2025-01-15Clinical Trial Update: Adebrelimab and Chemoradiotherapy in High-risk LANPC [Phase 2]
A Phase 2 clinical trial evaluating Adebrelimab in combination with chemoradiotherapy for high-risk locally advanced nasopharyngeal carcinom…
-
CLINICAL_TRIALS research · 2025-01-15Clinical Trial Update: Reducing Dose and Irradiated Volume in Cervical Prophylactic Irradiation for Nasopharyngeal Cancer [Phase 3]
This Phase 3 trial investigates whether reducing the radiation dose and irradiated volume during cervical prophylactic irradiation is effect…
-
CLINICAL_TRIALS research · 2025-01-14Clinical Trial Update: Monitoring Salivary Gland Injury in Nasopharyngeal Carcinoma Patients After Radiotherapy Using Multi-Modal Radiomics
This clinical trial protocol from Hainan Medical College aims to monitor salivary gland injury in nasopharyngeal carcinoma patients after ra…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-01-13Clinical Trial Update: Clinical Study of Mitoxantrone Hydrochloride Liposome Combined with PD-1 Blockade in Recurrent or Metastatic NPC [Phase 2]
Phase 2 trial evaluating mitoxantrone hydrochloride liposome combined with a PD-1 inhibitor for recurrent or metastatic nasopharyngeal carci…
-
CLINICAL_TRIALS research · 2025-01-13Clinical Trial Update: GP Vs PF As Induction Chemotherapy Combined with CCRT for Locoregionally Advanced Nasopharyngeal Carcinoma [Phase 3]
This document updates a Phase 3 trial comparing GP (gemcitabine plus cisplatin) versus PF (cisplatin plus fluorouracil) as induction chemoth…
-
CLINICAL_TRIALS research · 2025-01-13Clinical Trial Update: Tertiary Lymphoid Structures in Nasopharyngeal Carcinoma
This clinical trial update notes the status of a study on tertiary lymphoid structures in nasopharyngeal carcinoma, sponsored by Jiangxi Pro…
-
CLINICAL_TRIALS trial_result · 2025-01-10Clinical Trial Update: NPC - AXEL Study : Axitinib-Avelumab [Phase 2]
Phase 2 trial evaluating the axitinib-avelumab combination in recurrent or metastatic nasopharyngeal carcinoma has completed.
-
CLINICAL_TRIALS research · 2025-01-10Clinical Trial Update: Irinotecan Liposome Combined with S-1 in PD-1/L1 Inhibitor Refractory Recurrent or Metastatic NPC [Phase 2]
Phase 2 trial evaluating irinotecan liposome in combination with S-1 for PD-1/PD-L1 inhibitor-refractory recurrent or metastatic nasopharyng…
-
CLINICAL_TRIALS research · 2025-01-09Clinical Trial Update: Prognostic Value of CD4/CD8 Ratio in Patients with Nasopharyngeal Carcinoma
A clinical trial update evaluating whether the CD4/CD8 T-cell ratio has prognostic value in patients with Nasopharyngeal carcinoma who have …
-
CLINICAL_TRIALS research · 2025-01-09Clinical Trial Update: Prognostic Value of TIL in Nasopharyngeal Carcinoma
This entry reports a clinical trial evaluating the prognostic value of tumor-infiltrating lymphocytes in nasopharyngeal carcinoma; the study…
-
CLINICAL_TRIALS research · 2025-01-08Clinical Trial Update: Comparison of Multi-omics Models for Early Nasopharyngeal Carcinoma Screening: CfDNA Methylation, EBV DNA, and Serological Double-antibodies Detection
This clinical trial compares multi-omics approaches for early nasopharyngeal carcinoma screening by integrating cfDNA methylation, Epstein-B…
-
CLINICAL_TRIALS trial_result · 2024-12-31Clinical Trial Update: Neoadjuvant Chemotherapy and Low-dose Radiotherapy Sequential Concurrent Chemoradiotherapy for Locally Advanced Nasopharyngeal Carcinoma [NA]
This clinical trial update reports the completion of a study evaluating neoadjuvant chemotherapy and low-dose radiotherapy followed by seque…
-
CLINICAL_TRIALS other · 2024-12-30Clinical Trial Update: Nab-TPC vs GP Combined With Camrelizumab in the Treatment of Recurrent/Metastatic Nasopharyngeal Carcinoma [Phase 3]
Phase 3 trial update comparing Nab-TPC versus GP, both with camrelizumab, in recurrent/metastatic nasopharyngeal carcinoma; currently recrui…
-
CLINICAL_TRIALS trial_result · 2024-12-30Clinical Trial Update: Irinotecan Liposomes in Combination With Nituzumab for the Treatment of Recurrent/Metastatic Nasopharyngeal Carcinoma After Failure of First-Line or Higher Immunotherapy [Phase 2]
A Phase 2 clinical trial evaluating the combination of irinotecan liposomes with nituzumab for recurrent/metastatic nasopharyngeal carcinoma…
-
CLINICAL_TRIALS research · 2024-12-30Clinical Trial Update: Maintenance Therapy With Toripalimab Combined With Capecitabine/Placebo for Recurrent and Metastatic Nasopharyngeal Carcinoma [Phase 3]
Phase 3 trial update on maintenance therapy combining toripalimab with capecitabine versus placebo for recurrent/metastatic nasopharyngeal c…
-
CLINICAL_TRIALS research · 2024-12-30Clinical Trial Update: KSD-101 Therapy for Standard Treatment Failed EBV-associated Nasopharyngeal Carcinoma: an Exploratory Clinical Trial [EARLY_Phase 1]
Exploratory EARLY_PHASE1 trial of KSD-101 for EBV-associated nasopharyngeal carcinoma; the study is not yet recruiting.
-
CLINICAL_TRIALS research · 2024-12-30Clinical Trial Update: Sintilimab Combined With Bevacizumab and TP Chemotherapy in the Treatment of High Risk Locally-advanced NPC [Phase 2]
Phase 2 trial evaluating sintilimab plus bevacizumab and TP chemotherapy for high-risk locally advanced nasopharyngeal carcinoma; study not …
-
CLINICAL_TRIALS research · 2024-12-27Clinical Trial Update: Doxepin Solution for Alleviation of Stubborn Breakthrough Pain Induced by Swallowing in Patients Receiving Radiotherapy for Nasopharyngeal Carcinoma [NA]
A clinical trial is evaluating a doxepin solution to relieve swallowing-induced pain in patients receiving radiotherapy for nasopharyngeal c…
-
CLINICAL_TRIALS trial_result · 2024-12-19Clinical Trial Update: Cytotoxic T Cells to Treat Relapsed EBV-positive Lymphoma [Phase 1]
Phase 1 trial testing EBV-specific cytotoxic T cells in relapsed EBV-positive lymphomas has completed, assessing safety and preliminary acti…
-
CLINICAL_TRIALS research · 2024-12-13Clinical Trial Update: ChemoRT With and Without Dental Stent for Taste Protection in NPC Patients [Phase 2]
A Phase 2 study evaluating chemoradiation with vs without a dental stent for taste protection in nasopharyngeal carcinoma patients; the tria…
-
CLINICAL_TRIALS trial_result · 2024-12-12Clinical Trial Update: Toripalimab and Anlotinib Combination Treatment in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma After Failure of at Least One Line of Platinum-Based Chemotherapy (TORAL) [Phase 2]
TORAL is a Phase 2 trial evaluating toripalimab in combination with anlotinib for recurrent or metastatic nasopharyngeal carcinoma after pla…
-
CLINICAL_TRIALS research · 2024-12-05Clinical Trial Update: A Clinical Trial to Evaluate Effect of IAE0972 Combined with Chemotherapy for R/M HNSCC or NPC(Note: It is Currently Phase II.). [Phase 2, Phase 3]
A clinical trial evaluating the effect of IAE0972 in combination with chemotherapy for recurrent/metastatic head and neck squamous cell carc…
-
CLINICAL_TRIALS research · 2024-12-03Clinical Trial Update: The Role of Induction Gemcitabine and Cisplatin in Locoregionally Advanced Nasopharyngeal Carcinoma in the Era of IMRT [Phase 3]
Clinical trial update describing a Phase 3 study of induction gemcitabine and cisplatin for locoregionally advanced nasopharyngeal carcinoma…